Loeb S - Search Results

1

Evidence-Based Versus Personalized Prostate Cancer Screening: Using Baseline Prostate-Specific Antigen Measurements to Individualize Screening.

Loeb S. Loeb S. J Clin Oncol. 2016 Aug 10;34(23):2684-6. doi: 10.1200/JCO.2016.68.2138. Epub 2016 Jun 20. J Clin Oncol. 2016. PMID: 27325846 Free PMC article. No abstract available.

2

Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.

Loeb S, Roehl KA, Antenor JA, Catalona WJ, Suarez BK, Nadler RB. Loeb S, et al. Urology. 2006 Feb;67(2):316-20. doi: 10.1016/j.urology.2005.08.040. Epub 2006 Jan 25. Urology. 2006. PMID: 16442597

3

Pathological characteristics of prostate cancer detected through prostate specific antigen based screening.

Loeb S, Gonzalez CM, Roehl KA, Han M, Antenor JA, Yap RL, Catalona WJ. Loeb S, et al. J Urol. 2006 Mar;175(3 Pt 1):902-6. doi: 10.1016/S0022-5347(05)00327-7. J Urol. 2006. PMID: 16469576

4

Viewpoint: expanding prostate cancer screening.

Catalona WJ, Loeb S, Han M. Catalona WJ, et al. Among authors: loeb s. Ann Intern Med. 2006 Mar 21;144(6):441-3. doi: 10.7326/0003-4819-144-6-200603210-00012. Ann Intern Med. 2006. PMID: 16549857

5

Making prostate-specific antigen testing more effective.

Catalona WJ, Loeb S. Catalona WJ, et al. Among authors: loeb s. Urol Oncol. 2006 May-Jun;24(3):177-9. doi: 10.1016/j.urolonc.2005.09.001. Urol Oncol. 2006. PMID: 16678045 No abstract available.

6

Comparison of methods for calculating prostate specific antigen velocity.

Yu X, Han M, Loeb S, Gashti SN, Yeh JT, Roehl KA, Catalona WJ. Yu X, et al. Among authors: loeb s. J Urol. 2006 Dec;176(6 Pt 1):2427-31; discussion 2431. doi: 10.1016/j.juro.2006.08.006. J Urol. 2006. PMID: 17085120

7

Survival results in patients with screen-detected prostate cancer versus physician-referred patients treated with radical prostatectomy: early results.

Roehl KA, Eggener SE, Loeb S, Smith ND, Antenor JA, Catalona WJ. Roehl KA, et al. Among authors: loeb s. Urol Oncol. 2006 Nov-Dec;24(6):465-71. doi: 10.1016/j.urolonc.2005.11.039. Urol Oncol. 2006. PMID: 17138126

8

Prostate-specific antigen in clinical practice.

Loeb S, Catalona WJ. Loeb S, et al. Cancer Lett. 2007 Apr 28;249(1):30-9. doi: 10.1016/j.canlet.2006.12.022. Epub 2007 Jan 26. Cancer Lett. 2007. PMID: 17258389 Review.

9

Prostate specific antigen velocity threshold for predicting prostate cancer in young men.

Loeb S, Roehl KA, Catalona WJ, Nadler RB. Loeb S, et al. J Urol. 2007 Mar;177(3):899-902. doi: 10.1016/j.juro.2006.10.028. J Urol. 2007. PMID: 17296371

10

The association between total prostate specific antigen concentration and prostate specific antigen velocity.

Yu X, Loeb S, Roehl KA, Han M, Catalona WJ. Yu X, et al. Among authors: loeb s. J Urol. 2007 Apr;177(4):1298-302; discussion 1301-2. doi: 10.1016/j.juro.2006.12.003. J Urol. 2007. PMID: 17382716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results